CDLX - CIK 0001666071
Cardlytics, Inc. trades as CDLX. In its fiscal 2025 annual report the company posted revenue of $233.27M, down 16.2% from the prior year and net income of -$104.00M. This page tracks Cardlytics, Inc. through 1,000 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Cardlytics, Inc.'s revenue grew from $112.82M to $233.27M, a compound annual growth rate of 8.4%. Net profit margin expanded from -67.1% to -44.6% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Major company event | 8-K | 2026-05-20 |
| Insider trade | 4 | 2026-05-19 |
The largest companies sharing Cardlytics, Inc.'s SEC industry classification (services-computer programming, data processing, etc.).
Cardlytics, Inc. reported revenue of $233.27M for fiscal year 2025, a decrease of 16.2% year over year.
In its latest fiscal year Cardlytics, Inc. reported a net loss of $104.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.